Enveric Biosciences, Inc. (ENVB) Total Assets by Year
Enveric Biosciences, Inc. closed fiscal year 2025 with $5.1M in total assets, $918K in total liabilities and $4.2M in shareholder equity. This represents an increase of 65.3% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Enveric Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENVB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1510-K | FY1410-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1M+65.3% | $3.1M-28.3% | $4.3M-78.0% | $19.6M-26.8% | $26.7M+552.2% | $4.1M+3665.9% | $109K-99.6% | $29.6M-43.2% | $52.2M+32.1% | $39.5M+185.6% | $13.8M | $4.5M+29.7% | $3.4M | $6K-75.1% | $22K |
| Total Liabilities | $918K-38.4% | $1.5M-36.4% | $2.3M-41.4% | $4.0M-9.5% | $4.4M+547.8% | $681K-64.5% | $1.9M-93.5% | $29.7M-9.3% | $32.7M+17.6% | $27.8M+105.1% | $13.6M | $3.5M+15.7% | $3.0M | $26K+43.4% | $18K |
| Total Equity | $4.2M+162.3% | $1.6M-18.6% | $2.0M-86.7% | $14.7M-34.2% | $22.3M+553.1% | $3.4M+288.5% | -$1.8M-2667.7% | -$65K-100.3% | $19.4M+66.7% | $11.7M+4411.5% | $259K | $973K+129.1% | $425K | -$20K-540.5% | $5K |
ENVB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.9M+152.1% | $5.5M+8.2% | $5.1M+65.3% | $4.4M-8.9% | $3.5M-41.4% | $5.1M-42.3% | $3.1M-28.3% | $4.8M-27.6% | $6.1M-38.3% | $8.8M-44.2% | $4.3M-78.0% | $6.6M-78.5% |
| Total Liabilities | $861K-36.8% | $461K-61.1% | $918K-38.4% | $906K+8.0% | $1.4M+111.3% | $1.2M-50.0% | $1.5M-36.4% | $839K-79.9% | $645K-86.9% | $2.4M-56.5% | $2.3M-41.4% | $4.2M-42.3% |
| Total Equity | $8.1M+269.9% | $5.1M+29.2% | $4.2M+162.3% | $3.5M-12.5% | $2.2M-59.6% | $3.9M-39.6% | $1.6M-18.6% | $4.0M+62.2% | $5.4M+10.9% | $6.5M-37.7% | $2.0M-86.7% | $2.4M-89.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Enveric Biosciences, Inc. financials
Frequently Asked Questions
What was Enveric Biosciences, Inc.'s total assets in fiscal year 2025?
Enveric Biosciences, Inc. closed fiscal year 2025 with $5.1M in total assets, $918K in total liabilities and $4.2M in shareholder equity.
How fast is Enveric Biosciences, Inc.'s total assets growing?
Enveric Biosciences, Inc. (ENVB) total assets rose by 65.3% year over year, from $3.1M to $5.1M in fiscal year 2025.
How has Enveric Biosciences, Inc.'s total assets changed over the years?
Across the 15 fiscal years this page covers, Enveric Biosciences, Inc. (ENVB) total assets went from $22K in fiscal year 2011 to $5.1M in fiscal year 2025.
What was Enveric Biosciences, Inc.'s total assets in the most recent quarter?
Enveric Biosciences, Inc. (ENVB) reported $8.9M in total assets in Q2 2026. This represents an increase of 152.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Enveric Biosciences, Inc. (ENVB) reported on that line in every period on record.